Biopsy ME study - Node biopsy for patients with early stage Merkel Cell Carcinoma,
Not Applicable
Active, not recruiting
- Conditions
- Early stage (cT1N0) Merkel Cell CarcinomaCancer - Non melanoma skin cancer
- Registration Number
- ACTRN12618000528257
- Lead Sponsor
- South Western Sydney Local Health District
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
Patients (male or female) above 18 years old
Histologically documented cutaneous MCC, stage cT1N0
Suitable for sentinel lymph node biopsy
No clinical evidence of regional or distant metastases.
Patients must undergo treatment and follow up at Peter MacCallum Cancer Centre, Melbourne or the Liverpool hospital, Sydney.
Exclusion Criteria
Proven metastatic disease
Patients who refuse radiotherapy
Patients who refuse to join the trial or are unable to consent
Patients not being considered for further therapy
Patients who cannot lie still for at least 30 minutes or comply with imaging
Technically unsuitable for for lymphoscintigraphy/ SNB procedure
Pregnancy/Lactation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method